Internal Medicine, Hematology & Oncology · Germantown, TN
NPI
1780927244
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7945 Wolf River Blvd
Germantown, TN, 38138
Phone (901) 683-0055
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
116,877 services
Medicare patients, 2024
694
Average age 74
Drug cost, 2024
$2.3M
2,015 prescriptions
Company payments, 2025
$62K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason Porter was code J9271 (injection, pembrolizumab, 1 mg), 13,900 times for 31 patients. In total Jason Porter billed 116,877 services in 205 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,900 | 31 | $44.97 | $625K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 11,915 | 39 | $2.34 | $28K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,277 | 19 | $0.08 | $424 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 5,220 | 12 | $39.57 | $207K |
| J0897 Injection, denosumab, 1 mg | Office | 4,320 | 40 | $20.83 | $90K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,322 | 113 | $0.09 | $206 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,740 | 17 | $35.94 | $63K |
| Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | Office | 1,320 | 11 | $20.77 | $27K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,200 | 12 | $16.35 | $20K |
| 85025 Blood Count | Office | 965 | 209 | $7.59 | $7,325 |
| 80048 Clinical Chemistry | Office | 820 | 195 | $8.27 | $6,784 |
| 80076 Clinical Chemistry | Office | 790 | 191 | $7.99 | $6,314 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 680 | 43 | $0.76 | $517 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 549 | 23 | $0.23 | $125 |
| 36415 Venipuncture Blood Collection | Office | 511 | 150 | $8.62 | $4,403 |
By year: 2022 $1.0M for 58,737 services; 2023 $1.1M for 54,886 services; 2024 $2.3M for 116,877 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 965 | 209 | $7.59 | $7,325 |
| 80048 Clinical Chemistry | 820 | 195 | $8.27 | $6,784 |
| 80076 Clinical Chemistry | 790 | 191 | $7.99 | $6,314 |
| 36415 Venipuncture Blood Collection | 511 | 150 | $8.62 | $4,403 |
| 83735 Clinical Chemistry | 166 | 44 | $6.57 | $1,091 |
| 84443 Clinical Chemistry | 119 | 33 | $16.46 | $1,959 |
| 82565 Clinical Chemistry | 99 | 65 | $4.98 | $493 |
| 83550 Clinical Chemistry | 95 | 64 | $8.57 | $814 |
| 83540 Clinical Chemistry | 95 | 64 | $6.34 | $602 |
| 82728 Clinical Chemistry | 82 | 52 | $13.36 | $1,096 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason Porter prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 143 prescriptions and refills. In total Jason Porter wrote 2,015 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 143 | 143 | 30 | $3,777 |
| Prednisone Generic | 139 | 166 | 60 | $508 |
| Prochlorperazine Maleate Generic | 133 | 133 | 71 | $1,644 |
| Ondansetron Hcl Generic | 108 | 108 | 62 | $895 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 100 | 100 | 35 | $2,344 |
| Potassium Chloride Generic | 97 | 134 | 27 | $583 |
| Dexamethasone Generic | 95 | 95 | 42 | $944 |
| Eliquis Apixaban | 92 | 114 | 23 | $68K |
| Oxycodone Hcl Generic | 65 | 65 | 14 | $1,422 |
| Alprazolam Generic | 59 | 59 | 14 | $136 |
| Gabapentin Generic | 53 | 58 | 16 | $321 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 45 | 51 | 13 | $1,353 |
| Xarelto Rivaroxaban | 39 | 59 | Under 11 | $34K |
| Levothyroxine Sodium Generic | 37 | 65 | Under 11 | $308 |
| Omeprazole Generic | 33 | 58 | 11 | $250 |
Brand drugs: 415 claims; generic drugs: 1,600 claims; opioid claims: 333.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason Porter $62K ($62K in general payments such as food, travel and fees) from 19 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $18K |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $16K |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $12K |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $7,375 |
| Novocure Inc. NVCR | 3 | $2,899 |
| Pfizer Inc. PFE | 2 | $2,179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,740 |
| EMD Serono, Inc. MRK.DE | 2 | $365 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $244 |
| Janssen Biotech, Inc. JNJ | 2 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.